Showing results (551-560 of 744) with videos related to

Sort By:
Pageof 75
Environmental Health Perspectives|May 15, 2009
PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer riskKathleen M McCarty, Regina M Santella, Susan E Steck, et al.
Gynecologic Oncology|February 26, 2020
A modern assessment of the surgical pathologic spread and nodal dissemination of endometrial cancerAaron M Praiss, Yongmei Huang, Caryn M St Clair, et al.
Nutrition and Cancer|March 28, 2013
Nutrient pathways and breast cancer risk: the Long Island Breast Cancer Study ProjectPatrick T Bradshaw, Nikhil K Khankari, Susan L Teitelbaum, et al.
Breast Cancer Research and Treatment|June 4, 2008
BRCA1 promoter methylation is associated with increased mortality among women with breast cancerXinran Xu, Marilie D Gammon, Yujing Zhang, et al.
Discovery Medicine|January 31, 2012
Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapyTristan M Sissung, Sarah M Troutman, Tessa J Campbell, et al.
Cancer Biology & Therapy|November 30, 2012
Histone deacetylase inhibitors induce CXCR4 mRNA but antagonize CXCR4 migrationCaterina Ierano, Agnes Basseville, Kenneth K W To, et al.
Molecular Cancer Therapeutics|December 20, 2007
Novel E-ring camptothecin keto analogues (S38809 and S39625) are stable, potent, and selective topoisomerase I inhibitors without being substrates of drug efflux transportersKazutaka Takagi, Thomas S Dexheimer, Christophe Redon, et al.
Cancers|December 30, 2025
CA19-9 as a Dynamic Biomarker for Continuous Monitoring of Therapeutic Efficacy in Pancreatic AdenocarcinomaLuigi Brancato, Damar Osok, Laurent Van den Bossche, et al.
Breast Cancer Research and Treatment|November 13, 2023
Analysis of data from the PALOMA-3 trial confirms the efficacy of palbociclib and offers alternatives for novel assessment of clinical trialsCeline Yeh, Mengxi Zhou, Neil Bapodra, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 23, 2013
Overlapping substrate and inhibitor specificity of human and murine ABCG2Joshua Bakhsheshian, Matthew D Hall, Robert W Robey, et al.
Pageof 75